ASPIRE Cardiovascular, a Pfizer-supported independent competitive grants program, is awarding individual grants of up to $200,000 from a total fund of $2 million to support projects which bring new insights or advance the understanding of the role of the PCSK9 protein/gene in health and disease.

The application deadline has passed.

For additional research funding opportunities and resources, visit ACC.org/ResearchFunding.